Back to resultsNaltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Primary Purpose
Alcohol-Related Disorders, Cocaine-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Naltrexone
Sponsored by
About this trial
This is an interventional treatment trial for Alcohol-Related Disorders focused on measuring alcohol dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- University of Texas Health Science Center
Outcomes
Primary Outcome Measures
Verified abstinence from cocaine
Secondary Outcome Measures
Full Information
NCT ID
NCT00000307
First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
University of Texas
1. Study Identification
Unique Protocol Identification Number
NCT00000307
Brief Title
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Official Title
Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
April 2003 (undefined)
Primary Completion Date
April 2007 (Actual)
Study Completion Date
April 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
University of Texas
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol-Related Disorders, Cocaine-Related Disorders
Keywords
alcohol dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Naltrexone
Primary Outcome Measure Information:
Title
Verified abstinence from cocaine
Time Frame
over the 12 weeks of study
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Grabowski, Ph.D.
Organizational Affiliation
University of Texas
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas Health Science Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77225
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
We'll reach out to this number within 24 hrs